Last reviewed · How we verify
prednisone, colecalciferol, lactose
Prednisone is a corticosteroid that suppresses the immune system by inhibiting the production of inflammatory cytokines.
Prednisone is a corticosteroid that suppresses the immune system by inhibiting the production of inflammatory cytokines. Used for Rheumatoid arthritis, Multiple sclerosis, Asthma.
At a glance
| Generic name | prednisone, colecalciferol, lactose |
|---|---|
| Also known as | Miflonide, Pulmicort |
| Sponsor | Medical University of Lodz |
| Drug class | Corticosteroid |
| Target | Glucocorticoid receptor |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | Phase 3 |
Mechanism of action
Prednisone works by binding to the glucocorticoid receptor, which then translocates to the nucleus and regulates the transcription of genes involved in inflammation. This leads to a decrease in the production of pro-inflammatory cytokines, such as IL-1 and TNF-alpha, and an increase in the production of anti-inflammatory cytokines, such as IL-10. As a result, prednisone reduces inflammation and suppresses the immune system.
Approved indications
- Rheumatoid arthritis
- Multiple sclerosis
- Asthma
- Allergic reactions
Common side effects
- Weight gain
- Insomnia
- Mood changes
- Osteoporosis
- Glucose intolerance
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- prednisone, colecalciferol, lactose CI brief — competitive landscape report
- prednisone, colecalciferol, lactose updates RSS · CI watch RSS
- Medical University of Lodz portfolio CI